Pharmaceutical Innovation Hits the Wall: How Open Innovation Can Help
April 11, 2011 By Henry Chesbrough
ABSTRACT:
An article from the founder of Open Innovation, Harvard professor Henry Chesbrough, on the crisis facing pharmaceuticals. With $50 billion in expiring patents the industry is struggling to develop new pharmaceutical products. The stakes are high for the corporations, employees, and the practice of medicine. Chesbrough relays how open innovation should be used to accomplish industry goals.
[READ THE FULL ARTICLE]